Limited Submission Opportunities
(Applications through UCSF Limited Submission Program)
- Internal deadline: March 6, 2024 at noon
V Foundation Translational Cancer Research Grant
Adult cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms.The research should apply in some direct way to human beings within the time frame of less than 3 years from the end of the grant.
- Internal deadline: March 13, 2024
UCSF Society of Hellman Fellows Program
This program aims to provide short-term support for outstanding faculty at the assistant professor level whose work shows originality and promise of distinction, and to assist promising early career faculty who face challenges in advancing their work to the level of career development and eventual independence.
Intramural Funding Opportunities
For questions about intramural awards, please contact Meredith Donnelly.
- Deadline: Feb 29, 2024
UCRI California Firefighter Cancer Prevention and Research Program
The State of California has designated $7 million to the University of California (UC) Office of the President, per AB 700, for community-based participatory research projects to reduce the incidence of cancer among California firefighters.
- Deadline: March 4, 2024
UCSF RAP Spring 2024 Cycle
The UCSF Resource Allocation Program (RAP) offers a single online application process for a variety of intramural grants. Grants of interest include:
- Deadline: March 14, 2024
HDFCCC Neurologic Oncology Program RFA
The Neurologic Oncology Program is requesting applications from Program members for pilot research projects.
- Deadline: March 15, 2024
HDFCCC Cancer Immunology and Immunotherapy Program RFA
The Cancer Immunology and Immunotherapy Program is requesting applications from Program members for pilot research projects.
- Deadline: March 15, 2024
HDFCCC Diversity, Equity, Inclusion and Accessibility Mini-Grants
The HDFCCC Office of DEIA is offering four types of mini-grants to Cancer Center faculty, staff, and trainees: (1) Administrative Support, (2) Professional Development, (3) Community Building, and (4) Conference Travel.
- Deadline: March 22, 2024
CRISPR Cures for Cancer RFP
The CRISPR Cures for Cancer Initiative requests proposals that support our vision of a future of precise, genetically engineered, immune cell therapies accessible to patients across the full range of human cancers. We seek proposals for high-risk, high-reward projects developing or applying genomic technologies to the understanding and treatment of human cancer using next-generation cell-based therapies. Proposals should take account of the Initiative long-term goal of accelerating progress to cancer cures.
- Deadline: March 31, 2024
HDFCCC Cancer Control Program RFA
The Cancer Control Program is requesting applications from active Cancer Control Program members for pilot research projects.
- LOI Deadline: Mar 18, 2024
Global Health Research Seed Funding Grant
A grant will be awarded to provide funds to develop exciting investigator-initiated concepts focused on global health research, which will hopefully lead to successful longer term project funding from the NIH or equivalent funding sources. [Contact: [email protected]]
- Deadline: Apr 18, 2024
Gateway for Cancer Research Grant Opportunities
Gateway for Cancer Research funds early phase investigator-initiated oncology trials focusing on: new investigational therapies, new indications, de-escalation of treatment, mitigation of treatment toxicity, predictive biomarkers (with a therapeutic component), and integrative medicine within the overall research areas of Biomarkers (prognostic or predictive with supportive treatment), Gene Therapy, Basket Trials, Immunotherapy, and Targeted Therapies. [UCSF contact for questions: [email protected]]
- Deadline: May 13, 2024
Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA) for Early-Stage Investigator Physicians
Winn CDA is a 2-year program designed to support the career development of early-stage investigator physicians who are underrepresented in medicine (URiM) or who have a demonstrated commitment to increasing diversity in clinical research. (Cancer Center members may reach out to Robbie Díaz at [email protected] to request support with their applications.)
- Deadline: May 15, 2024
Laboratory for Genomics Research (LGR) Innovation Award
The Laboratory for Genomics Research (LGR) Innovation Awards program aims to support early-stage technology development projects that could mature into future UC-LGR collaborative projects. Innovation Awards are one-year research grants to support labs at the UCSF and UC Berkeley campuses with an interest in developing highly innovative ideas into early proofs of concept across the field of functional genomics and CRISPR/Cas-based tool development. The goal for these awards is to support the development of novel platform technologies, disease-related model systems, and the application of these to functional genomics screens. The award is open to Faculty or faculty-equivalent status with primary appointments at UC San Francisco and UC Berkeley.
If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.
- Due Apr 5: Administrative Supplements for P30 Cancer Centers Support Grants to Stimulate Research in HIV/AIDS Cancer Research Projects at NCI-Designated Cancer Centers
- Due Apr 5: Administrative Supplements for P30 Cancer Centers Support Grants to Stimulate Research in Immunotherapy and Tumor Microenvironment in HIV/AIDS Cancer Patients at NCI-Designated Cancer Centers
- Due Apr 5: Administrative Supplements for P30 Cancer Centers Support Grants to Stimulate Research in HIV-Associated Cancers in Aging Populations
- Due Sept 6: NCI Administrative Supplements to Support Cancer Disparity Collaborative Research
To view NCI funding opportunities, search here